戻る Agenda
Session 2 Track 1: Extra-Hepatic Delivery – Clinical Experience: Emerging
Session Chair(s)
Xing Jing, PhD, MBA
Clinical Pharmacology Reviewer, CBER, FDA, United States
Arthur A. Levin, PhD
Distinguished Scientist, Avidity Biosciences, United States
Track 1: Extra-Hepatic Delivery – Clinical Experience: Emerging
Speaker(s)
James Hamilton, MD, MBA
Chief of Discovery and Transitional Medicine, Arrowhead Pharmaceuticals, United States
Pulmonary Delivery Platform and Clinical Programs
Thomas Thum, MD, PhD, FACC
CSO/CMO, Cardior Pharmaceuticals GmbH, Germany
Cardiac Delivery of Oligonucleotides
Allison August
Chief Medical Officer, Comanche Biopharma, United States
Delivery of siRNA to Placenta for Treatment of Preeclampsia
Steve Hughes, MD, MBA
Chief Medical Officer, Atrium Therapeutics, United States
Delivery of Oligonucleotides to Muscle in Patients